+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 3 Actively Recruiting clinical trials

T

Actively Recruiting

Researchers are evaluating a targeted water, sanitation, and hygiene WASH intervention to reduce cholera and severe diarrhea among household members of diarrhea patients in South Kivu, Democratic Republic of the Congo. The study includes formative research and a randomized controlled trial to assess how effective the intervention is at lowering diarrheal diseases and improving WASH behaviors within these households. It also investigates transmission dynamics of cholera and severe diarrhea using genomics and risk factor analysis. The study has two phases first, developing the WASH intervention through research and community engagement second, implementing and evaluating it in a randomized trial. In the trial, households are assigned to either the PICHA7 mHealth program or the standard message given in DRC health facilities. The PICHA7 program includes an in-person delivery of a pictorial WASH module by a health promoter, two home visits during the 7-day high-risk period, and a diarrhea prevention package with chlorine tablets, soapy water, a handwashing station, and a water vessel with lid and tap. Afterward, households receive weekly voice and text messages for 12 months promoting recommended WASH behaviors. Participants include diarrhea patients and their household members who will be followed for 12 months. Researchers will assess diarrhea occurrences among household members as the primary outcome. Secondary measures include child development, handwashing behaviors, water quality, presence of bacteria in stored water, psychosocial factors related to WASH, and growth measurements in children under 5 years. Data collection occurs at multiple time points up to 24 months. The study will monitor adherence to interventions and evaluate the impact on diarrheal disease transmission within households.

All AgesAll GendersPhase Not Applicable
2 locations
I

Actively Recruiting

Healthy Volunteer

Rift Valley fever RVF is a disease transmitted from livestock to humans, commonly occurring in East and Central Africa where major epidemics have been reported over the past 50 years. Researchers are investigating the burden of RVF and other infectious diseases in hotspots across Kenya, Uganda, Tanzania, and the Democratic Republic of Congo during periods between outbreaks. This study aims to understand how the virus circulates among humans, wildlife, and livestock to support early warning and prevention strategies. The study includes multiple approaches such as hospital-based surveillance of patients with acute fever, community surveys of livestock and humans, sampling at slaughter houses, wildlife sampling, and mosquito vector studies. These efforts span several years and involve testing blood and tissue samples for RVF virus and other pathogens using molecular and serological techniques. Modeling studies will further analyze ecological and climatic factors affecting virus transmission. Participants will be involved in providing blood samples, answering questionnaires about animal contact and behaviors, and may be followed for up to two years after enrollment. Researchers will monitor virus exposure, identify risk factors, and evaluate disease presence using laboratory tests and surveys. The study also includes analysis of archived samples and ongoing monitoring of mosquito populations to better understand and predict RVF outbreaks in the region.

Age: 2Years +All Genders
10 locations
E

Actively Recruiting

Researchers are evaluating a new method using SDS-EDTA-treated chromatography paper strips for collecting and transporting samples to detect mpox virus. This observational study compares this method to the standard swab-based sampling among patients with suspected mpox infection in healthcare facilities in the Democratic Republic of the Congo. The aim is to assess the diagnostic accuracy and practical use of the strip method in field conditions. Participants will have paired samples taken simultaneously using both the standard swab method and the SDS-EDTA strip method from skin lesions suitable for sampling. The chromatography strip contains SDS, which inactivates the virus to reduce biosafety risks during transport, and EDTA, which stabilizes nucleic acids and lessens the need for cold storage. Samples collected are analyzed using local molecular diagnostic platforms. During the study, participants will be assessed based on their clinical signs and suitability of lesions for paired sampling. Researchers will measure the difference in mpox virus detection between the two sampling methods through laboratory analysis of samples collected up to six months after collection. Safety and consent procedures are in place, and total participation duration depends on sample collection and analysis timelines.

All AgesAll Genders
1 location